Cross-presentation of tumor antigens by bone marrow derived antigen-presenting cells (APCs) is the dominant mechanism in tolerance induction to B-cell lymphomas.

被引：0
|
作者：
Sotomayor, EM
Borrello, I
Rattis, FM
Abrams, J
Levitsky, HI
机构：
[1] H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA
[2] Johns Hopkins Oncol Ctr, Baltimore, MD USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2795
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 48 条
  • [21] UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells
    Salame, Natasha
    Bikorimana, Jean-Pierre
    El-Hachem, Nehme
    Saad, Wael
    Kurdi, Mazen
    Zhao, Jing
    Eliopoulos, Nicoletta
    Shammaa, Riam
    Rafei, Moutih
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [22] Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance
    Berg, Martina
    Wingender, Gerhard
    Djandji, Dominik
    Hegenbarth, Silke
    Momburg, Frank
    Hämmerling, Guenter
    Limmer, Andreas
    Knolle, Percy
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (11) : 2960 - 2970
  • [23] Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation
    Sigal, LJ
    Rock, KL
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08): : 1143 - 1150
  • [24] DIFFERENTIAL PRESENTATION OF HEPATITIS-B S-PRES(2) PARTICLES AND PEPTIDES BY MACROPHAGES AND B-CELL LIKE ANTIGEN-PRESENTING CELLS
    SCHEERLINCK, JPY
    BURSSENS, G
    BRYS, L
    MICHEL, A
    HAUSER, P
    DEBAETSELIER, P
    IMMUNOLOGY, 1991, 73 (01) : 88 - 94
  • [25] INDUCTION OF PERIPHERAL TOLERANCE BY INTRATHYMIC INOCULATION OF SOLUBLE ALLOANTIGENS - EVIDENCE FOR THE ROLE OF HOST ANTIGEN-PRESENTING CELLS AND SUPPRESSOR-CELL MECHANISM
    OLUWOLE, SF
    JIN, MX
    CHOWDHURY, NC
    ENGELSTAD, K
    OHAJEKWE, OA
    JAMES, T
    CELLULAR IMMUNOLOGY, 1995, 162 (01) : 33 - 41
  • [26] STI-571, a selective tyrosine kinase inhibitor, significantly enhances antigen presentation by bone marrow derived APCs: Implications for immunotherapy of tumors-derived from antigen presenting cells.
    Wang, HW
    Cheng, FD
    Cuenca, AG
    Bhalla, K
    Sotomayor, EM
    BLOOD, 2001, 98 (11) : 16A - 16A
  • [27] Reduced antigen-presenting ability of bone marrow-derived dendritic cells from ultraviolet-B-irradiated or Hapten-Painted mice
    Gorman, S.
    Lee, J.
    Hart, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S42 - S42
  • [28] Induction of CD4+CD25+Treg by tolerance-inducing antigen-presenting cells derived from bone marrow cultures cultured with CD200R2/3
    Gorczynski, R
    FASEB JOURNAL, 2005, 19 (04): : A359 - A359
  • [29] Antigen presentation by bone-marrow derived antigen presenting cells is required for effective T-cell priming in an animal model of autoimmune liver disease
    Derkow, K.
    Kruse, N.
    Klugewitz, K.
    Wiedenmann, B.
    Schott, E.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S13 - S13
  • [30] Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
    Nowak, AK
    Lake, RA
    Marzo, AL
    Scott, B
    Heath, WR
    Collins, EJ
    Frelinger, JA
    Robinson, BWS
    JOURNAL OF IMMUNOLOGY, 2003, 170 (10): : 4905 - 4913
12345